S4120-117 · 117th Congress
Signed into Law
Signed Jan 5, 2023Childhood Cancer STAR Reauthorization Act
Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 or the Childhood Cancer STAR Reauthorization Act This bill reauthorizes through FY2028 and modifies pediatric cancer research and related programs, including to expand collection of and access to relevant biospecimens and to support the transition of pediatric cancer survivors to primary care.
VOTE BREAKDOWN
No recorded floor vote
Most bills never receive a recorded roll-call vote — they're referred to committee and don't advance to the floor. The sponsor and funding context on this page still tells you who is behind it and what industries have a stake.
SPONSORS
Jack Reed
D-RI · Primary
29 COSPONSORS
BIPARTISANSPONSOR FUNDING
Top industries funding Reed
Defense & Aerospace13%
Lawyers & Lobbyists12%
Labor Unions11%
Single-Issue Advocacy10%
Securities & Investment8%
TRAIL AI
The Childhood Cancer Survivorship, Treatment, Access, and Research (STAR) Reauthorization Act, introduced by Senator Jack Reed of Rhode Island, reauthorizes federal programs related to childhood cancer survivorship and research. The bill was signed into law during the 117th Congress. Specific voting data for this legislation is not yet available.
Based on public voting records. Does not imply causation.
TIMELINE
INTRODUCEDApr 28, 2022
PASSED SENATEDec 20, 2022
SIGNEDJan 5, 2023
DATA SOURCES
Bill data: Congress.gov · 117th–119th Congress (2021–present)
Vote records: House Clerk / Senate · 2021–present
Reflects public records. Does not imply causation.
